First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Tangible Net Worth Ratio
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued tangible net worth ratio. First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($257.46 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of First Tracks Biotherapeutics, Inc. Ordin to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
Tangible net worth ratio of First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024. This chart shows how First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's Tangible Net Worth Ratio has changed across 2 annual periods from 2023 to 2024. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $257.46 Million with intangible assets of $0.00 USD. Check TRAXV PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Tangible Net Worth Ratio by Year (2023–2024)
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued tangible net worth ratio by year from 2023 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see First Tracks Biotherapeutics, Inc. Ordin market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $391.60 Million | $0.00 | $441.89 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $409.85 Million | $0.00 | $444.11 Million | — |